P032 The pharmacological profile of TOP1288, a narrow spectrum kinase inhibitor in clinical development as an anti-inflammatory treatment for ulcerative colitis

Abstract

Background: Intracellular kinase activation plays a key role in inflammation and kinase inhibitors have been proposed as potential therapy for chronic inflammatory disorders such as ulcerative colitis. Selective kinase inhibitors have proved disappointing, particularly in the treatment of rheumatoid